HCW Biologics Inc (HCWB)
0.7374
-0.26
(-26.26%)
USD |
NASDAQ |
Jun 21, 16:00
0.9709
+0.23
(+31.67%)
After-Hours: 20:00
HCW Biologics Shareholders Equity (Quarterly): 8.741M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 8.741M |
December 31, 2023 | 13.46M |
September 30, 2023 | 23.87M |
June 30, 2023 | 28.59M |
March 31, 2023 | 32.62M |
December 31, 2022 | 37.43M |
September 30, 2022 | 42.56M |
Date | Value |
---|---|
June 30, 2022 | 46.17M |
March 31, 2022 | 49.40M |
December 31, 2021 | 51.19M |
September 30, 2021 | 54.01M |
June 30, 2021 | 8.864M |
March 31, 2021 | 11.58M |
December 31, 2020 | 14.40M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
8.741M
Minimum
Mar 2024
54.01M
Maximum
Sep 2021
30.20M
Average
30.60M
Median
Shareholders Equity (Quarterly) Benchmarks
CEL-SCI Corp | 14.30M |
AIM ImmunoTech Inc | 4.826M |
IGC Pharma Inc | 9.053M |
NovaBay Pharmaceuticals Inc | 0.16M |
Protalix BioTherapeutics Inc | 29.79M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 30.43M |
Total Liabilities (Quarterly) | 21.69M |
Debt to Equity Ratio | 0.9606 |
Current Ratio | 0.4629 |
Net Debt Paydown Yield | -0.60% |